Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
348
NCT00567086
Study to Assess the Safety, Tolerance and Efficacy of Tezampanel in Patients With Acute Migraine
Phase: Phase 2
Role: Lead Sponsor
Start: Oct 31, 2006
Completion: Aug 31, 2007
NCT00637793
Study of NGX267 Oral Capsules in Patients With Xerostomia Associated With Sjorgren's Syndrome
Start: Feb 29, 2008
Completion: Nov 30, 2008
NCT00832546
A Safety Tolerance and Experimental Hyperalgesia Study of Oral NGX426 in Healthy Male Voluneteers
Phase: Phase 1
Start: May 31, 2008
Completion: Sep 30, 2008